Pink SheetUpcoming federal spending reductions and resulting coverage losses in Medicaid could have a significant impact on patient access to drugs for HIV, cystic fibrosis and mental health, as well as treatme
The pharmaceutical market is notoriously difficult to predict. Drug developers and the analysts who cover them must navigate a landscape shaped by geopolitical shifts, financial pressures and regulato
In VivoWhen Abbas Kazimi became CEO of Nimbus Therapeutics in March 2025, he didn’t need to introduce a sweeping new three-year vision. After 11 years at the company, having witnessed its evolution from a bo
ScripLeo Pharma’s mission to be the partner of choice in the field of medical dermatology has been bolstered by an eye-catching deal to commercialize and further develop Boehringer Ingelheim’s flagship ski